6317-97-1 Usage
General Description
4,6-Dihydroxy-5-nitropyridine-3-carboxylic acid ethyl ester is a chemical compound that belongs to the class of pyridine derivatives. It is synthesized from 4,6-dihydroxy-5-nitropyridine-3-carboxylic acid and ethyl ester. 4,6-Dihydroxy-5-nitropyridine-3-carboxylic acid ethyl ester has been studied for its potential pharmacological and pharmaceutical applications, including its use as a building block in the synthesis of other organic compounds. It has also been investigated for its potential biological activities, such as its antioxidant and anti-inflammatory properties. Overall, 4,6-Dihydroxy-5-nitropyridine-3-carboxylic acid ethyl ester is a versatile and potentially useful chemical compound with a range of potential applications in various fields.
Check Digit Verification of cas no
The CAS Registry Mumber 6317-97-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,3,1 and 7 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 6317-97:
(6*6)+(5*3)+(4*1)+(3*7)+(2*9)+(1*7)=101
101 % 10 = 1
So 6317-97-1 is a valid CAS Registry Number.
InChI:InChI=1/C8H8N2O6/c1-2-16-8(13)4-3-9-7(12)5(6(4)11)10(14)15/h3H,2H2,1H3,(H2,9,11,12)
6317-97-1Relevant articles and documents
Discovery and SAR study of 2-(1-propylpiperidin-4-yl)-3H-imidazo[4,5-c]pyridine-7-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase-1 (PARP-1) for the treatment of cancer
Zhu, Qihua,Wang, Xueyan,Hu, Yan,He, Xiaorong,Gong, Guoqing,Xu, Yungen
, p. 6551 - 6559 (2015/10/19)
A series of imidazo[4,5-c]pyridine-7-carboxamide derivatives as poly(ADP-ribose) polymerase (PARP) inhibitors have been developed. All target compounds were evaluated for their PARP-1 inhibitory activity and some were further assessed for cellular potency
NEW MACROLIDES AND THEIR USE
-
Page/Page column 79, (2009/10/21)
The invention relates to macrolide compounds of formula (I),the use of said compounds as medicaments, in particular for the treatment or prevention of inflammatory and allergic diseases, pharmaceutical compositions containing said compounds and to process
